4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide
Chemical Structure Depiction of
4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide
4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide
Compound characteristics
Compound ID: | L610-0139 |
Compound Name: | 4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide |
Molecular Weight: | 488.63 |
Molecular Formula: | C29 H36 N4 O3 |
Smiles: | CC1CCN(CCCNC(c2ccc(CN3C(C4CCCN4C(c4ccccc34)=O)=O)cc2)=O)CC1 |
Stereo: | RACEMIC MIXTURE |
logP: | 2.3307 |
logD: | -0.1295 |
logSw: | -2.9579 |
Hydrogen bond acceptors count: | 7 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 60.51 |
InChI Key: | XPTHDLBJOFUQBT-SANMLTNESA-N |